Tirza Injection 7.5 mg/0.5 ml contains Tirzepatide, a once-weekly injectable medication used in the management of type 2 diabetes mellitus. It is a dual GIP and GLP-1 receptor agonist that helps improve glycemic control and supports weight reduction when used alongside diet and exercise.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Indications

Tirza Injection 7.5 mg is indicated for:

• Type 2 diabetes mellitus as an adjunct to diet and exercise
• Patients requiring additional glycemic control after lower-dose therapy
• Support in weight management for overweight or obese individuals (as prescribed by a physician)

Mechanism of Action

Tirzepatide works by activating two incretin pathways:

• GLP-1 receptor activation: Enhances glucose-dependent insulin secretion, suppresses glucagon release, slows gastric emptying, and increases satiety
• GIP receptor activation: Improves insulin sensitivity and glucose utilization

Together, these actions provide enhanced blood sugar control and contribute to reduced appetite and weight loss.

Dosage and Administration

• Administered as a subcutaneous injection once weekly
• Dose escalation should be gradual and guided by a healthcare professional
• Inject into the abdomen, thigh, or upper arm
• Rotate injection sites each week
• Use on the same day each week for best results

Benefits

• Improved long-term blood glucose control
• Enhanced weight reduction support
• Reduced appetite and caloric intake
• Once-weekly convenient dosing
• Supports overall metabolic health improvement

Side Effects

Common side effects may include:

• Nausea
• Vomiting
• Diarrhea or constipation
• Reduced appetite
• Abdominal discomfort

Less common but serious side effects:

• Pancreatitis
• Gallbladder disorders
• Hypoglycemia (especially with insulin or sulfonylureas)
• Dehydration-related kidney issues

Precautions and Warnings

• Not indicated for type 1 diabetes
• Use cautiously in patients with a history of pancreatitis
• Maintain adequate hydration during therapy
• Not recommended during pregnancy or breastfeeding unless clearly needed
• Regular blood glucose monitoring is required
• Dose adjustments must be done under medical supervision

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Drug Interactions

Tirza Injection 7.5 mg may interact with:

• Insulin and sulfonylureas (risk of hypoglycemia)
• Other antidiabetic agents
• Medications affecting gastrointestinal motility

Inform your healthcare provider about all ongoing treatments.

Storage

• Store in a refrigerator at 2°C to 8°C
• Do not freeze
• Protect from light
• Keep out of reach of children.